Quality of life measures in soft tissue sarcoma

References

• Barr RD, Wunder JS. Bone and soft tissue sarcomas are often curable-But at what cost? Cancer 2009;115(18):4046-54
   PubMedGoogle Scholar
• Davis AM, O’Sullivan B, Turcotte R, et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol 2005;75(1):48-53
   PubMed Web of Science ®Google Scholar
• Pervaiz N, Colterjohn N, Farrokhyar F, et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 2008;113(3):573-81
   PubMed Web of Science ®Google Scholar
• Woll PJ, Reichardt P, Le Cesne A, et al. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol 2012;13(10):1045-54
   PubMed Web of Science ®Google Scholar
• Ménard C, Merckaert I, Razavi D, Libert Y. Decision-making in oncology. Curr Opin Oncol 2012;24(4):381-90
   PubMedGoogle Scholar
• Quinten C, Coens C, Mauer M, et al. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol 2009;10(9):865-71
   PubMed Web of Science ®Google Scholar
• Basch E, Abernethy AP, Mullins CD, et al. Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol 2012;30(34):4249-55
   PubMed Web of Science ®Google Scholar
• Washington AE, Lipstein SH. The p-centered outcomes research institute—promoting better information, decisions, and health. N Engl J Med 2011;365(15):e31
   PubMed Web of Science ®Google Scholar
• Davis AM, Wright JG, Williams JI, et al. Development of a measure of physical function for patients with bone and soft tissue sarcoma. Qual Life Res 1996;5(5):508-16
   PubMed Web of Science ®Google Scholar
• Davis AM. Functional outcome in extremity soft tissue sarcoma. Semin Radiat Oncol 1999;9(4):360-8
   PubMed Web of Science ®Google Scholar
• Davis AM, Sennik S, Griffin AM, et al. Predictors of functional outcomes following limb salvage surgery for lower-extremity soft tissue sarcoma. J Surg Oncol 2000;73(4):206-11
   PubMed Web of Science ®Google Scholar
• Townley WA, Mah E, O’Neill AC, et al. Reconstruction of sarcoma defects following pre-operative radiation: free tissue transfer is safe and reliable. J Plast Reconstr Aesthet Surg 2013;66(11):1575-9
   PubMed Web of Science ®Google Scholar
• Gundle KR, Cizik AM, Punt SEW, et al. Validation of the SF-6D health state utilities measure in lower extremity sarcoma. Sarcoma 2014;2014(34):1-4
   Google Scholar
• Enneking WF. Limb Salvage in Musculoskeletal Oncology. Churchill Livingstone; New York: 1987
   Google Scholar
• Enneking WF, Dunham W, Gebhardt MC, et al. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res 1993(286):241-6
   PubMed Web of Science ®Google Scholar
• Davis AM, Bell RS, Badley EM, et al. Evaluating functional outcome in patients with lower extremity sarcoma. Clin Orthop Relat Res 1999(358):90-100
   PubMedGoogle Scholar
• Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30(6):473-83
   PubMed Web of Science ®Google Scholar
• Zeltzer LK, Lu Q, Leisenring W, et al. Psychosocial outcomes and health-related quality of life in adult childhood cancer survivors: a report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev 2008;17(2):435-46
   PubMed Web of Science ®Google Scholar
• Davis AM. Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol 2002;20(22):4472-7
   PubMed Web of Science ®Google Scholar
• Gafni A. The standard gamble method: what is being measured and how it is interpreted. Health Serv Res 1994;29(2):207-24
   PubMed Web of Science ®Google Scholar
• Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 2005;43(3):203-20
   PubMed Web of Science ®Google Scholar
• Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21(2):271-92
   PubMed Web of Science ®Google Scholar
• Färkkilä N, Torvinen S, Roine RP, et al. Health-related quality of life among breast, prostate, and colorectal cancer patients with end-stage disease. Qual Life Res 2013;23(4):1387-94
   PubMedGoogle Scholar
• Pickard AS, Wilke CT, Lin H-W, Lloyd A. Health utilities using the EQ-5D in studies of cancer. Pharmacoeconomics 2007;25(5):365-84
   PubMed Web of Science ®Google Scholar
• Reichardt P, Leahy M, Garcia del Muro X, et al. Quality of life and utility in patients with metastatic soft tissue and bone sarcoma: the Sarcoma Treatment and Burden of Illness in North America and Europe (SABINE) Study. Sarcoma 2012;2012(11):1-11
   Google Scholar
• Pickard AS, De Leon MC, Kohlmann T, et al. Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Med Care 2007;45(3):259-63
   PubMed Web of Science ®Google Scholar
• Ware JE, Snow KK, Kosinski M, Gandek B. New England Medical Center Hospital. Health Institute. SF-36 Health Survey. New England Medical Center Hospital. Health Institute; Boston: 1993
   Google Scholar
• Kharroubi SA, Brazier JE, Roberts J, O’Hagan A. Modelling SF-6D health state preference data using a nonparametric Bayesian method. J Health Econ 2007;26(3):597-612
   PubMedGoogle Scholar
• Hays RD, Reeve BB, Smith AW, Clauser SB. Associations of cancer and other chronic medical conditions with SF-6D preference-based scores in Medicare beneficiaries. Qual Life Res 2013;23(2):385-91
   PubMedGoogle Scholar
• MD LL, Elfassy N, Li C, et al. Valuing postoperative recovery: validation of the SF-6D health-state utility. J Surg Res. 2013;184(1):108-14
   Google Scholar
• Horsman J, Furlong W, Feeny D, Torrance G. The health utilities index (HUI): concepts, measurement properties and applications. Health Qual Life Outcomes 2003;1:54
   PubMedGoogle Scholar
• Butt Z, Reeve B. Enhancing the Patient’s Voice: standards in the design and selection of patient-reported outcomes measures (PROMs) for use in patient-centered outcomes research. www.pcori.org 2012. [Accessed 30 June 2014] pp 1-53. www.pcori.org/assets/Enhancing-the-Patients-Voice-Standards-in-the-Design-and-Selection-of-Patient-Reported-Outcomes-Measures-for-Use-in-Patient-Centered-Outcomes-Research.pdf
   Google Scholar
• Acaster S, Cimms T, Lloyd A. The design and selection of patient-reported outcomes measures (PROMs) for use in patient centered outcomes research. www.pcori.org 2012. [Accessed 2014 June 30] pp 1-85. www.pcori.org/assets/The-Design-and-Selection-of-Patient-Reported-Outcomes-Measures-for-Use-in-Patient-Centered-Outcomes-Research1.pdf
   Google Scholar